Safety content examination and deliberation in international medical center of Japan

• In: Hospital Pharmacy - Posters
• At: Basel (Switzerland) (2008)
• Type: Poster
• Poster code: HPS-P-039
• By: SAKAMOTO, Yuka (International Medical Center of Japan, Tokyo, Japan)
• Co-author(s): Kubota, Atsushi (International Medical Center of Japan, TOKYO, Japan)
  Atsuta, Kazuyoshi (International Medical Center of Japan, TOKYO, Japan)
  Yoshino, Nobutsugu (International Medical Center of Japan, TOKYO, Japan)
  Okazaki, Osamu (International Medical Center of Japan, TOKYO, Japan)
  Uemura, Naomi (International Medical Center of Japan, TOKYO, Japan)
  Kondo, Naoki (National Cancer Center, Japan)
  
• Abstract:

  When I observe a serious adverse event regarding the investigational product, the sponsor promptly notifies the head of the trial site and an investigator. The head of the trial site that receives the notice, must render an opinion about the appropriateness of the enforcement continuation for the institutional review board (IRB). When the IRB is

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login